相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease
Susanne A. Schneider et al.
JOURNAL OF NEUROLOGY (2020)
Potential Roles of Exosomes in Parkinson's Disease: From Pathogenesis, Diagnosis, and Treatment to Prognosis
Haiyang Yu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease A Phase 2 Randomized Clinical Trial
Fernando. L. Pagan et al.
JAMA NEUROLOGY (2020)
Atomoxetine Does Not Improve Complex Attention in Idiopathic Parkinson's Disease Patients with Cognitive Deficits: A Meta-Analysis
Abhinaba Ghosh et al.
PARKINSONS DISEASE (2020)
Gut Microbiota Altered in Mild Cognitive Impairment Compared With Normal Cognition in Sporadic Parkinson's Disease
Tengzhu Ren et al.
FRONTIERS IN NEUROLOGY (2020)
Cognitive impairment in Parkinson's disease: A clinical and pathophysiological overview
Pedro Renato P. Brandao et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials
Jennifer G. Goldman et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease
Vasiliki Orgeta et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial
C. R. A. Silveira et al.
BMC NEUROLOGY (2019)
Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study
Peter Novak et al.
PLOS ONE (2019)
Transcranial magnetic stimulation improves cognition over time in Parkinson's disease
Jessica Trung et al.
PARKINSONISM & RELATED DISORDERS (2019)
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
Klaus Seppi et al.
MOVEMENT DISORDERS (2019)
Transcranial direct current stimulation enhances theory of mind in Parkinson's disease patients with mild cognitive impairment: a randomized, double-blind, sham-controlled study
Mauro Adenzato et al.
TRANSLATIONAL NEURODEGENERATION (2019)
Personalized transcranial alternating current stimulation (tACS) and physical therapy to treat motor and cognitive symptoms in Parkinson's disease: A randomized cross-over trial
Alessandra Del Felic et al.
NEUROIMAGE-CLINICAL (2019)
Transcranial Magnetic Stimulation Does Not Improve Mild Cognitive Impairment in Parkinson's Disease
Isabelle Buard et al.
MOVEMENT DISORDERS (2018)
Aerobic exercise is more effective than goal-based exercise for the treatment of cognition in Parkinson's disease
Carolina R. A. Silveira et al.
BRAIN AND COGNITION (2018)
Transcranial direct current stimulation combined with cognitive training for the treatment of Parkinson Disease: A randomized, placebo-controlled study
Rosa Manenti et al.
BRAIN STIMULATION (2018)
Risk factors for non-motor symptoms in Parkinson's disease
Johan Marinus et al.
LANCET NEUROLOGY (2018)
Effects of physical exercise programs on cognitive function in Parkinson's disease patients: A systematic review of randomized controlled trials of the last 10 years
Franciele Cascaes da Silva et al.
PLOS ONE (2018)
Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review
Arun T. Nair et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2018)
Bilateral Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson Disease Dementia A Randomized Clinical Trial
James Gratwicke et al.
JAMA NEUROLOGY (2018)
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-a-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease A Randomized Clinical Trial
Joseph Jankovic et al.
JAMA NEUROLOGY (2018)
Cognitive Training and Transcranial Direct Current Stimulation for Mild Cognitive Impairment in Parkinson's Disease: A Randomized Controlled Trial
Blake J. Lawrence et al.
PARKINSONS DISEASE (2018)
First-in-human assessment of PRX002, an anti--synuclein monoclonal antibody, in healthy volunteers
Dale B. Schenk et al.
MOVEMENT DISORDERS (2017)
Metabolic Profiling of Parkinson's Disease and Mild Cognitive Impairment
Florence Burte et al.
MOVEMENT DISORDERS (2017)
Cognitive decline in Parkinson disease
Dag Aarsland et al.
NATURE REVIEWS NEUROLOGY (2017)
The impact of Tai Chi and Qigong mind-body exercises on motor and non-motor function and quality of life in Parkinson's disease: A systematic review and meta-analysis
R. Song et al.
PARKINSONISM & RELATED DISORDERS (2017)
A Randomized Clinical Trial of Atomoxetine for Mild Cognitive Impairment in Parkinson's Disease
Vanessa K. Hinson et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2017)
Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial
Daniel Weintraub et al.
MOVEMENT DISORDERS (2016)
Nilotinib Effects in Parkinson's Disease and Dementia with Lewy Bodies
Fernando Pagan et al.
JOURNAL OF PARKINSONS DISEASE (2016)
Exercise for Individuals with Lewy Body Dementia: A Systematic Review
Michael Inskip et al.
PLOS ONE (2016)
Outcome Measures for Parkinson's Disease Dementia: A Systematic Review
Samantha K. Holden et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2016)
Cognitive function in the early phase of Parkinson's disease, a five-year follow-up
M. E. Domellof et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis
Chris Stinton et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Double-blind Randomized Trial of t-DCS Versus Sham in Parkinson Patients With Mild Cognitive Impairment Receiving Cognitive Training
Roberta Biundo et al.
BRAIN STIMULATION (2015)
Tango for treatment of motor and non-motor manifestations in Parkinson's disease: A randomized control study
Silvia Rios Romenets et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2015)
The Effect of Creatine and Coenzyme Q10 Combination Therapy on Mild Cognitive Impairment in Parkinson's Disease
Zhenguang Li et al.
EUROPEAN NEUROLOGY (2015)
Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo-controlled study
Eugenia Mamikonyan et al.
MOVEMENT DISORDERS (2015)
Cognitive training in Parkinson's disease reduces cognitive decline in the long term
A. Petrelli et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies
Keith A. Wesnes et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2015)
Long-term Safety of Rivastigmine in Parkinson Disease Dementia: An Open-Label, Randomized Study
Murat Emre et al.
CLINICAL NEUROPHARMACOLOGY (2014)
Depression and Cognitive Impairment in Parkinson's Disease: A Role for Inflammation and Immunomodulation?
Natalia Pessoa Rocha et al.
NEUROIMMUNOMODULATION (2014)
Effects of tDCS on executive function in Parkinson's disease
Deniz Doruk et al.
NEUROSCIENCE LETTERS (2014)
Effects of cognitive training in Parkinson's disease: A randomized controlled trial
Annette Petrelli et al.
PARKINSONISM & RELATED DISORDERS (2014)
The Effects of Adapted Tango on Spatial Cognition and Disease Severity in Parkinson's Disease
Kathleen E. McKee et al.
JOURNAL OF MOTOR BEHAVIOR (2013)
Prognosis of Mild Cognitive Impairment in Early Parkinson Disease
Kenn Freddy Pedersen et al.
JAMA NEUROLOGY (2013)
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial
Suzanne Craft et al.
ARCHIVES OF NEUROLOGY (2012)
Donepezil in Parkinson's disease dementia: A randomized, double-blind efficacy and safety study
Bruno Dubois et al.
MOVEMENT DISORDERS (2012)
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
Irene Litvan et al.
MOVEMENT DISORDERS (2012)
The Effects of Rasagiline on Cognitive Deficits in Parkinson's Disease Patients Without Dementia: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Hasmet A. Hanagasi et al.
MOVEMENT DISORDERS (2011)
The epidemiology of dementia associated with Parkinson disease
Dag Aarsland et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
D. Weintraub et al.
NEUROLOGY (2010)
Atomoxetine for the Treatment of Executive Dysfunction in Parkinson's Disease: A Pilot Open-Label Study
Laura Marsh et al.
MOVEMENT DISORDERS (2009)
Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-β in memory-impaired older adults
Mark A. Reger et al.
JOURNAL OF ALZHEIMERS DISEASE (2008)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
A systematic review of prevalence studies of dementia in Parkinson's disease
D Aarsland et al.
MOVEMENT DISORDERS (2005)
Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study
B Ravina et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Rivastigmine for dementia associated with Parkinson's disease
M Emre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease
I Leroi et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2004)
Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease
KA Jellinger et al.
JOURNAL OF NEURAL TRANSMISSION (2002)
分享论文
